Simplex Trading, LLC Genprex, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$1.0 - $58.8 $14,766 - $868,240	-14,766 Reduced 64.89%	7,991 $11,000
Q3 2022 Nov 04, 2022	BUY	$1.32 - $58.0 $30,039 - $1.32 Million	22,757 New	22,757 $32,000
Q2 2021 Aug 12, 2021	SELL	$3.11 - $4.87 $160,737 - $251,701	-51,684 Reduced 64.33%	28,657 $96,000
Q1 2021 Apr 26, 2021	BUY	$3.66 - $7.67 $69,265 - $145,154	18,925 Added 30.81%	80,341 $346,000
Q4 2020 Feb 02, 2021	BUY	$3.03 - $5.51 $167,234 - $304,113	55,193 Added 886.92%	61,416 $0
Q3 2020 Oct 14, 2020	SELL	$2.9 - $4.29 $46,727 - $69,124	-16,113 Reduced 72.14%	6,223 $0
Q2 2020 Jul 13, 2020	BUY	$1.99 - $3.64 $43,557 - $79,672	21,888 Added 4885.71%	22,336 $70,000
Q1 2020 Apr 29, 2020	BUY	$0.28 - $6.23 $125 - $2,791	448 New	448 $1,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $112M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.